OTC:GWLL | Free Cash Flow | GOLDENWELL BIOTECH, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13,361.00
2025-12-31-$18,848.00
2025-06-30$59,380.00
2025-03-31-$32,276.00
2024-12-31-$25,351.00
2024-06-30-$47,751.00
2024-03-31-$29,010.00
2023-12-31-$19,076.00
2023-09-30-$35,210.00
2023-06-30-$26,946.00
2023-03-31-$31,921.00
2022-12-31-$917,090.00
2022-09-30$15,222.00
2022-06-30-$25,037.00
2022-03-31-$145,655.00
2021-12-31-$19,373.00
2021-09-30-$12,506.00
2021-06-30-$150,201.00
2021-03-31-$150,200.00
2020-12-31-$2,975.00
2020-03-31-$2,329.00
2019-12-31-$2,311.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$22,629.00
2024-12-31-$123,077.00
2023-12-31-$113,153.00
2022-12-31-$1.07M
2021-12-31-$205,138.00
2020-12-31-$6,324.00
2019-12-31-$2,311.00